GlassScriptPhysician profile
Edward D Tillett
NPI 1700838703
$2,127.61
in general payments reported to CMS, 2019-2025
21 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $281 · 2021: $192 · 2022: $247 · 2023: $252 · 2024: $188 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $881.19 | 2019-2022 | |
| Stryker Corporation | $304.57 | 2019-2024 | Iconix, Alphavent |
| Bioventus LLC | $171.34 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $135.93 | 2022-2023 | Evos |
| Linvatec Corporation | $118.17 | 2023 | Biobrace 23mm |
| Pfizer INC. | $77.67 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $67.62 | 2021-2023 | Iovera, Zilretta, Exparel |
| Sanofi-Aventis U.S. LLC | $48.74 | 2019 | |
| Alpha Orthopedic Systems | $45.81 | 2020 | |
| Abbvie INC. | $45.02 | 2023-2025 | Dalvance |
| Orthofix Medical, INC. | $37.57 | 2022-2025 | Physio-Stim |
| Ethicon US, LLC | $28.17 | 2025 | Ethicon, Stratafix |
| Vertex Pharmaceuticals Incorporated | $27.96 | 2025 | |
| Convatec INC. | $27.43 | 2024 | |
| Medtronic, INC. | $23.61 | 2025 | Synchromedii |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $21.42 | 2023 | |
| Depuy Synthes Sales INC. | $16.13 | 2019 | |
| Melinta Therapeutics, LLC | $14.57 | 2023 | Orbactiv, Kimyrsa |
| Dynasplint Systems INC. | $12.18 | 2023 | Dynasplint |
| Flowonix Medical Incorporated | $11.61 | 2019 | |
| Ferring Pharmaceuticals INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Tillett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.